Event Details
- Location: London
- Date: Thursday 30th June 2022
- Price: £Free
(Non-Members: £50.00)
Our regular free to PLG members event will be held in London on Thursday 30 June 2022 at The Institute of Cancer Research’s Chester Beatty Labs.
Attendees are invited to arrive from 4.30pm for registration, with the afternoon presentations starting from 5pm. We are pleased to confirm our great line up of speakers:
5.10pm – David Copping, Partner, Farrer & Co
Identifying and commercialising non-patented IP: the legal framework
5.35pm – Bruce Hellman, Co Founder & Chief Patient Officer, uMotif
uMotif – our IP journey from digital health startup to eClinical software platform for clinical trials
6pm – Simon Rasalingham, Chairman & CEO, behold.ai
AI accelerated diagnosis from behold.ai – why should big Pharma be interested?
6.25pm – Summary
6.30pm – Networking drinks reception
8.30pm – Close
To book your place please visit PLG Summer Meeting Online Registration
Guest places are available for a small registration fee.
Farrer & Co LLP Event Sponsor |
The Institute of Cancer Research Event Host |
4.30pm | Registration |
5pm | Welcome & PLG Update |
5.05pm | Introduction JON WILKINSON Deputy Director and Head of Business Development and Licensing The Institute of Cancer Research |
Chair TOBY RICHARDSON Senior Director, Early Innovation Partnering Immunology, EMEA Johnson & Johnson Innovation |
|
5.10pm | Presentation 1 DAVID COPPING Partner Farrer & Co Identifying and commercialising non-patented IP: the legal framework Spotting and capturing value Dealing with data, software, algorithms and analytics Know-how and trade secrets The power of brands |
5.35pm | Presentation 2 BRUCE HELLMAN Co-Founder & Chief Patient Officer uMotif uMotif - our IP journey from digital health startup to eClinical software platform for clinical trials What we've protected What we can't How to build non-protectable value Opportunities for pharma Focusing on the real 'job to be done' |
6pm | SIMON RASALINGHAM Chairman & CEO behold.ai AI accelerated diagnosis from behold.ai - why should big Pharma be interested? |
6.25pm | Summary & Wrap-up |
6.30pm | Networking Drinks Reception |
8.30pm | Close |
Institute of Cancer Research
Chester Beatty Labs
237 Fulham Road
London
SW3 6JB
You must be logged in to access the downloads.